| Patents for A61K 9 - Medicinal preparations characterised by special physical form (299,044) |
|---|
| 06/23/1991 | CA2072010A1 Use of a material, the main constituent of which is a triglyceride, as an agent with biological effect on the intestinal mucosa and preparation containing such agent |
| 06/23/1991 | CA2032956A1 Spray drying process for making pharmaceutical powder compositions directly compressible into tablets |
| 06/22/1991 | WO1991009989A1 A method for applying a hard coating on cores of adible or chewable material and coated material obtained by the method |
| 06/22/1991 | CA2070288A1 Method for applying a hard coating on cores of edible or chewable material and coated material obtained by the method |
| 06/22/1991 | CA2032446A1 Nicotine packaging materials |
| 06/21/1991 | WO1991008764A1 SOLUBILIZATION OF t-PA |
| 06/21/1991 | WO1991008757A1 Method of treating ocular diseases by periocular administration of cyclosporine a or g |
| 06/21/1991 | CA2071900A1 Method of treating ocular diseases by periocular administration of cyclosporine a or g |
| 06/21/1991 | CA2032366A1 Ophthalmic medication |
| 06/20/1991 | WO1991008738A1 Compositions and method for treating painful, inflammatory or allergic disorders |
| 06/20/1991 | DE3941703A1 Pharmaceutical compsns. contg. bumetanid for treatment of hypertonia - contg. pellets, 30 per cent of which give quick release and rest giving slow release of active ingredient |
| 06/20/1991 | DE3941582A1 Pharmazeutische praeparate Pharmaceutical products |
| 06/19/1991 | WO1991008678A1 Sustained flavorant release composition, method for making same and chewable structure incorporating same |
| 06/19/1991 | EP0433242A1 Vaccines and process for their preparation |
| 06/19/1991 | EP0433140A1 New anti-allergic sustained-release pharmaceutical preparation |
| 06/19/1991 | EP0433132A1 Cosmetic compositions for topical application comprising essential oils |
| 06/19/1991 | EP0433086A1 Sunscreen compositions |
| 06/19/1991 | EP0433074A1 Method for treating cardiac malfunction |
| 06/19/1991 | EP0433004A2 Long lasting flavour release in confectionery compressed tablets |
| 06/19/1991 | EP0432956A1 Pharmaceutical lozenges |
| 06/19/1991 | EP0432945A1 A transdermal delivery system for treatment of cocaine and heroin addiction |
| 06/19/1991 | EP0432693A1 Liposomes cytotoxic to virus-infected cells |
| 06/19/1991 | EP0432638A1 Combination preparations comprising chloramphenicol, gentamicin and nystatin as active substances for topical treatment of skin inflammation diseases |
| 06/19/1991 | EP0432607A1 Tablets with controlled-rate release of active substances |
| 06/19/1991 | EP0432494A2 Pour-on formulations effective for the control of internal and external parasites of homothermic animals |
| 06/19/1991 | EP0432479A1 Anhydrous pharmaceutical formulations and dosage forms for the rectal administration of calcitonin |
| 06/19/1991 | EP0432443A1 Polyester based on 4-hydroxyalkanoic acids and process for their preparation |
| 06/19/1991 | EP0432431A1 Liquid pharmaceutical composition for nasal administration containing a polypeptide as active ingredient |
| 06/19/1991 | EP0432232A1 Process for producing small particles of biologically active molecules. |
| 06/19/1991 | EP0282495B1 Xylometazolin-containing pharmaceuticals |
| 06/19/1991 | EP0207100B1 Process for changing the effective pore size of a structure |
| 06/19/1991 | CA2071958A1 Sustained flavorant release composition, method for making same and chewable structure incorporating same |
| 06/18/1991 | US5025004 Water-dispersible polymeric compositions |
| 06/18/1991 | US5024998 Pharmaceutical formulations for parenteral use |
| 06/18/1991 | US5024997 Aqueous solution with sweetener and cyclodextrin derivate; for oral administration |
| 06/18/1991 | US5024995 Phospholipids and proteins; free of carbohydrates, cholesterol and triglycerides |
| 06/18/1991 | US5024843 Time-release tablet; unaffected by gastrointestinal environment |
| 06/18/1991 | US5024842 Annealed coats |
| 06/18/1991 | CA1284994C Cephalosporin salts and injectable compositions |
| 06/15/1991 | WO1991008793A1 A treatment system for wounds and other disorders and a method for treating wounds and other skin disorders |
| 06/15/1991 | CA2032211A1 Long lasting flavor release in confectionery compressed tablets with multiple encapsulation system |
| 06/15/1991 | CA2031873A1 Iontophoretic delivery method |
| 06/14/1991 | CA2032105A1 Cosmetic composition for topical application containing essential oils |
| 06/14/1991 | CA2032079A1 Method for treating cardiac malfunction |
| 06/13/1991 | WO1991008736A1 Plasma-irradiated solid preparation |
| 06/13/1991 | WO1991007998A1 IMPROVED SYSTEM FOR THE TRANSDERMAL APPLICATION OF PHARMACOLOGICALLY ACTIVE COMPOUNDS AT CONTROLLED pH |
| 06/13/1991 | WO1991007997A1 An aerosol preparation of glutathione and a method for augmenting glutathione level in lungs |
| 06/13/1991 | WO1991007971A1 Composition for rectal administration |
| 06/13/1991 | WO1991007969A1 Use of caffeine in the treatment of herpes simplex virus infections |
| 06/13/1991 | WO1991007964A1 Fat emulsion |
| 06/13/1991 | WO1991007962A1 Fat emulsion |
| 06/13/1991 | WO1991007952A1 Method of producing compacted dispersable systems |
| 06/13/1991 | WO1991007951A1 Homologous guluronic acid alginate coating composition for in-vivo application and implantation and method of using same |
| 06/13/1991 | WO1991007950A1 Pharmaceutical compositions |
| 06/13/1991 | WO1991007948A1 Pancreatin preparations |
| 06/13/1991 | WO1991007945A1 Utilization of xanthines, optionally incorporated in liposomes in order to help the pigmentation of skin or hair |
| 06/13/1991 | CA2069440A1 An aerosol preparation of glutathione and a method for augmenting glutathione level in lungs |
| 06/13/1991 | CA2042393A1 Plasma-irradiated solid preparation |
| 06/13/1991 | CA2032004A1 Method for treatment of cocaine and heroin addiction comprising transdermal delivery of buprenorphine |
| 06/12/1991 | EP0432117A1 Composition for treatment of inflammation |
| 06/12/1991 | EP0431942A2 Percutaneously absorbable pharmaceutical preparation containing dopamine derivative |
| 06/12/1991 | EP0431877A1 Cimetidine pharmaceutical compositions |
| 06/12/1991 | EP0431811A1 Thrombolytic agents |
| 06/12/1991 | EP0431759A1 Process for the preparation of a ranitidine resin absorbate |
| 06/12/1991 | EP0431719A1 Vaginal tissue moisturizing composition |
| 06/12/1991 | EP0431663A1 Stabilized solutions of psychotropic agents |
| 06/12/1991 | EP0431659A1 Pharmaceutical compositions of tebufelone |
| 06/12/1991 | EP0431519A1 System for transdermal albuterol administration |
| 06/12/1991 | EP0431376A1 Hard confections containing hydrogenated isomaltulose and a medicinally active ingredient |
| 06/12/1991 | EP0431371A1 3-Aminopyrroles, process for this preparation and their use as medicaments |
| 06/12/1991 | EP0431135A1 Particle-mediated transformation of animal somatic cells |
| 06/12/1991 | EP0198034B1 Physiological means of enhancing transdermal delivery of drugs |
| 06/12/1991 | CN1052046A Pharmaceutical preparations |
| 06/12/1991 | CN1052044A Process and apparatus for preparing control agent of medicine release |
| 06/12/1991 | CA2031973A1 Liposomes cytotoxic to virus-infected cells |
| 06/11/1991 | US5023355 Heating and stirring to disperse in a polysorbate in an inert atmosphere; adding antioxidants and cooling |
| 06/11/1991 | US5023271 Pharmaceutical microemulsions |
| 06/11/1991 | US5023257 Related to ciprofloxacin, in the form of oily suspension; bacterial infections |
| 06/11/1991 | US5023252 Using heterocyclic oxygen, sulfur, or nitrogen containing compound |
| 06/11/1991 | US5023251 O/W cream containing hydrocortisone diester |
| 06/11/1991 | US5023245 Improved niacin formulation |
| 06/11/1991 | US5023242 Formed with organic acids; antibiotics; antimicrobial bandage, wound dressing |
| 06/11/1991 | US5023108 Aqueous dispersions of waxes and lipids for pharmaceutical coating |
| 06/11/1991 | US5023089 Sustained-release preparations and the process thereof |
| 06/11/1991 | US5023088 Multi-unit delivery system |
| 06/11/1991 | US5023087 Mixture of empty liposomes with those containing encapsulated drugs; antibiotic |
| 06/11/1991 | US5023086 In lipid vesicles |
| 06/11/1991 | US5023085 Transdermal flux enhancers in combination with iontophoresis in topical administration of pharmaceuticals |
| 06/11/1991 | US5023084 Transdermal estrogen/progestin dosage unit, system and process |
| 06/11/1991 | US5023083 Oral administration of encapsulated azarbine which is soluble in intestines; prevention of vitamin B6 deficiency |
| 06/11/1991 | US5023082 Liquid precursor comprising plasticizer, active material, crosslinking agent, water soluble crosslinkable protein; biodegradable |
| 06/11/1991 | US5023081 Controlled release hydroxybutyrate polymer microspheres |
| 06/11/1991 | US5023080 Time release protein |
| 06/11/1991 | US5023076 Drug delivery |
| 06/11/1991 | US5023024 Process for producing microcapsules |
| 06/07/1991 | CA2031243A1 Preparation for endermism containing dopamine derivative |
| 06/06/1991 | WO1991007947A1 Neurologic agents for nasal administration to the brain |
| 06/06/1991 | DE3939926A1 Compression bandage comprising flat fabric - carrying suspension of peloid having good heating action |
| 06/06/1991 | DE3939703A1 Verbesserte transdermale applikation von pharmakologisch aktiven verbindungen Improved transdermal application of pharmacologically active compounds |
| 06/06/1991 | DE3939372A1 Mitonafide-infusionsloesung Mitonafide-infusion spoon |